Why Now Daily.

Published

D-Dimer Tests: Rule-Out Use and False Positives

D-dimer is a fragment produced as cross-linked fibrin in a clot is broken down. In a validated diagnostic pathway, a negative result can help exclude deep-vein thrombosis or pulmonary embolism in someone whose clinical probability is low enough. A positive result is nonspecific and usually leads to clinical…

Timeline

  1. 2023-08-02: NICE last updated its venous-thromboembolism diagnostic guideline, including COVID-19-related interpretation.
  2. 2025-03-05: CDC updated its public overview of DVT and pulmonary-embolism signs and symptoms.
  3. 2026-10-12: Current MedlinePlus, CDC and NICE D-dimer guidance was reviewed for this guide.

D-dimer is a small protein fragment released when the body breaks down cross-linked fibrin, the mesh that helps stabilize a blood clot. The test measures that fragment in blood. Because clot formation and breakdown can occur in many circumstances, the result is best understood as evidence about an active process, not as a picture of a clot and not as a diagnosis. Laboratories may report different units and cutoffs, so the flag and the exact assay both matter. [1][2]

Its main strength is ruling out venous thromboembolism in selected patients. Clinicians first estimate the probability of deep-vein thrombosis, or DVT, and pulmonary embolism, or PE, from symptoms, examination and risk factors, often using a validated score. NICE recommends D-dimer testing in specified lower-probability pathways. When a sufficiently sensitive test is negative within that pathway, the chance of VTE can be low enough that imaging is unnecessary. That conclusion cannot be transferred to a person with high clinical probability or to an unvalidated home interpretation. [2][3]

A positive D-dimer does not prove a clot. MedlinePlus lists pregnancy, heart disease, rheumatoid arthritis, recent surgery, older age and immobility among reasons a level may be high; trauma, infection, inflammation and other serious illness can also activate clotting and breakdown. The more common these alternative causes are in a population, the more positive results will be false positives for DVT or PE. A positive result therefore usually means that the diagnostic pathway continues, often with leg ultrasound or lung-vessel imaging chosen for the symptoms and circumstances. [1][2]

Age changes the tradeoff. D-dimer tends to rise with age, so one fixed cutoff produces more positive results and unnecessary imaging in older adults. NICE says clinicians should consider an age-adjusted threshold for people over 50, using an appropriate quantitative assay and local protocol. This is not permission to invent a cutoff from an internet formula. Assay units, calibration, the clinical pathway and local validation determine which threshold applies, and the adjustment still does not make a positive result diagnostic. [2][3]

Timing and treatment can complicate a negative result. MedlinePlus warns that blood-thinning medicines can cause a false negative, and clinicians also consider when symptoms began, whether a clot may be small or old, and whether the assay is sufficiently sensitive for the intended pathway. A portal value below a displayed limit should not overrule continuing or worsening symptoms. If clinical suspicion remains high, clinicians may proceed to imaging or repeat assessment even when D-dimer is not elevated. [1][2]

The test is only one branch of a larger evaluation. For suspected DVT, NICE begins with history, examination and a two-level Wells score, then directs patients to D-dimer or proximal-leg ultrasound according to probability and timing. For suspected PE it likewise uses clinical probability, with imaging or D-dimer in the appropriate branch. Some very-low-risk patients may be assessed with a separate rule such as PERC before testing. These tools require all of their criteria and professional judgment; mixing pieces from different pathways can make the apparent reassurance unsafe. [2]

Symptoms determine urgency, not the availability of a lab result. CDC lists swelling, pain or tenderness, warmth, and redness or discoloration in an affected leg or arm as common DVT signs. Difficulty breathing, fast or irregular heartbeat, chest pain that may worsen with a deep breath or cough, coughing blood, lightheadedness or fainting can signal PE and require immediate medical help. About half of people with DVT have no symptoms, and PE can occur without obvious DVT symptoms, so self-screening with signs or D-dimer is unreliable. [4]

When reading a result, ask four questions: why the test was ordered, what pretest probability pathway was used, which assay and threshold the laboratory applied, and what the next step is. Do not start or stop anticoagulants because of a D-dimer value; those medicines have meaningful bleeding and clotting consequences. A negative result can be powerful when used in the right low-probability pathway, while a positive result is a prompt for further evaluation. The distinction between rule-out evidence and diagnosis is the central point of the test. [1][2][3][4]

Sources

  1. MedlinePlus — D-Dimer Test
  2. NICE — Venous Thromboembolic Diseases: Recommendations
  3. NICE — Venous Thromboembolic Diseases: Rationale and Impact
  4. CDC — About Venous Thromboembolism (Blood Clots)

Related stories